Small interfering RNA (siRNA) technology harnesses the natural RNA interference (RNAi) pathway to achieve precise, sequence-specific gene silencing at the post-transcriptional level. By guiding the degradation of complementary mRNA molecules, siRNAs enable researchers to selectively downregulate gene expression, making them indispensable tools in functional genomics, drug discovery, and therapeutic development.
Key Applications of siRNA
- Targeted Gene Knockdown:
siRNAs allow efficient and specific silencing of disease-associated genes, facilitating the study of gene function and validation of therapeutic targets. - Cancer Research:
siRNA-based approaches are used to inhibit oncogenes and modulate tumor microenvironment components, as demonstrated by spatial transcriptomics revealing localized suppression of oncogenes and immune activation in cancer tissues. - Drug Discovery and Development:
Integration of siRNA with advanced models such as organ-on-a-chip systems accelerates screening of drug candidates and elucidation of molecular mechanisms. - Therapeutic Potential:
siRNA therapeutics are advancing in clinical pipelines for diseases including genetic disorders, viral infections, and cancers, offering highly specific treatment options.
